Ethics approval and consent to participate
-11
This study was a part of the Health Insurance Portability and Accountability Act compliant, adhered to the tenets of the Declaration of Helsinki, and was approved by the Institutional Review Board (IRB) of Catholic University of Korea Seoul St. Mary’s Hospital (IRB approval code: KC19MDDS0905), Kangbuk Samsung Hospital (IRB approval code: KBSMC 2019-11-002), Konyang University Hospital (IRB approval code: KYUH 2019-11-009-001), Kyungpook National University Hospital (IRB approval code: KNUH 2019-11-009), Korea University Guro Hospital (IRB approval code: 2020GR0017), Korea University Ansan Hospital (IRB approval code: 2019AS0275), Korea University Anam Hospital (IRB approval code: 2019AN0493), Pusan National University Hospital (IRB approval code: D-1912-001-096), Seoul National University Bundang Hospital (IRB approval code: B-2001/588 − 406), Samsung Medical Center (IRB approval code: SMC 2019-12-041-002), Seoul National University Hospital (IRB approval code: H-1911-101-1081), Asan Medical Center (IRB approval code: 2019 − 1559), Gangnam Severance Hospital (IRB approval code: 3-2019-0373), Severance Hospital (IRB approval code: 4-2019-1079), and Chungnam National University Hospital (IRB approval code: CNUH-2019-354). The protocol of this study was registered with ClinicalTrials.gov (Trial registration: ClinicalTrials, registration number: NCT05017844, first posted date: 24/08/2021, 